Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
Status:
Completed
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
To compare low dose (1mg) pitavastatin and high dose (4mg) pitavastatin on neointimal
hyperplasia and atherosclerosis progression by using optical coherence tomography (OCT) and
near-infrared spectroscopy (NIRS) at 12 months follow-up and on clinical adverse
cardiovascular events during 3-year follow-up.